“ipos” Archives

in
Entry Author Date Location
Biotech Roundup: CRISPR’s 3rd IPO, Gender Diversity, Buyouts & More 09/16/16 National
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials 06/29/16 Boston
Twilio’s $150M IPO May Bolster Faith In Unicorns—-Or Some Of Them 06/23/16 San Francisco
Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case 06/22/16 Boston
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials 06/06/16 Boston
Retooled Selecta Bio Takes Crossover Cash to IPO Queue 05/24/16 Boston
Syndax Cuts Price But Bags $53M in Second IPO Try 03/02/16 Boston
Proteostasis Cuts Price But Heads to Nasdaq After $50M IPO 02/11/16 Boston
The Big Value Creation Trend of 2015: Q&A with Jonathan Medved 12/22/15 National
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
Gene Therapy Startup Dimension Cuts Price But Bags $72M in IPO 10/21/15 Boston
East Coast Biotech Roundup: Collins, Disruptors, Biogen, & More 10/09/15 Boston
Bio Slump Hits IPOs as Edge, Mirna Cut Prices, Upsize to Close Deals 10/01/15 New York
Does Wall Street Combined With Silicon Alley Equal a “New” New York? 09/23/15 New York
Wayfair Learning E-Commerce Lessons From Amazon, Zulily 08/17/15 Boston
In Biotech, Everyone’s Going Public. What’s Your Excuse? 07/22/15 National
Tech Bubble Talk Focuses on IPO Dearth, Overpriced Rounds, and China 07/10/15 National
How Your Startup Can Run With Unicorns 06/26/15 Boston
U.S. IPO Activity Loses Steam to PE Deals in First Half of 2015 06/23/15 National
After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq 06/16/15 Boston
Winner Takes All? 06/12/15 Boston
To Back Startups, PureTech Heads Across the Pond For $160M London IPO 05/26/15 Boston
Nivalis Bets on Potential Cystic Fibrosis Drug, Seeks $60M IPO 05/14/15 Boulder/Denver
San Diego’s aTyr Pharma Raises Total Proceeds of $75M in IPO 05/06/15 San Diego
Blueprint Medicines Bags $147M in Upsized IPO 04/29/15 Boston
Viking Therapeutics Set to Make Nasdaq Debut Following IPO 04/29/15 San Diego
Head-Scratching VC Data 04/24/15 Boston
NEA Closes on $3.1 Billion for Its Latest Fund, Sticks to Its Strategy 04/15/15 New York
Page 1 of 17 next page »